Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA class I transgenic mice: development, utilisation and improvement.

Steve Pascolo1

  • 1Department of Immunology, University of Tübingen, Auf der Morgenstelle 15, 72076 Tübingen, Germany. steve.pascolo@uni-tuebingen.de

Expert Opinion on Biological Therapy
|July 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemically synthesized, non-capped and non-polyadenylated peptide-coding RNA efficiently induces antigen-specific CD8<sup>+</sup> T cells.

Nature biomedical engineering·2026
Same author

NLRP1 inflammasome activation in skin equivalents reveals mechanistic insights into the roles of keratinocytes in psoriasis.

Cell death & disease·2026
Same author

Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validation.

Molecular therapy. Nucleic acids·2025
Same author

Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models.

Science translational medicine·2025
Same author

Development of Thermostable and Immunogenic Block Copolymer Nanoparticles (BNPs) for mRNA Delivery.

Biomacromolecules·2025
Same author

LL37 complexed to double-stranded RNA induces RIG-I-like receptor signalling and Gasdermin E activation facilitating IL-36γ release from keratinocytes.

Cell death & disease·2025

Major histocompatibility complex (MHC) class I antigen processing differs between humans and mice. Genetically modified mice models help study human cytotoxic T cell immunity and immunotherapies.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Major histocompatibility complex (MHC) class I antigens are crucial for adaptive immunity, presenting peptides to T cells.
  • MHC I molecules are recognized by T cell receptors on CD8+ cytotoxic T lymphocytes (CTLs) and by natural killer cell receptors.
  • Their cellular production involves a complex interplay of proteases, chaperones, and transporters.

Purpose of the Study:

  • To compare the similarities and differences in human and mouse MHC class I antigen processing and presentation machinery.
  • To review the development and application of humanized mouse models for studying human CTL immunity.

Main Methods:

  • Comparative analysis of human and mouse MHC I antigen processing pathways.
  • Description of transgenesis, knockout, and knock-in technologies for creating immunologically humanized mice.

Related Experiment Videos

Main Results:

  • Identified key similarities and subtle differences between human and mouse MHC I antigen processing machineries.
  • Highlighted the utility of humanized mouse models for evaluating immunotherapies and characterizing MHC I peptide epitopes.

Conclusions:

  • Understanding the nuances of MHC I processing in different species is vital for effective immunotherapy development.
  • Humanized mouse models offer a powerful preclinical platform for advancing research in human CTL immunity and cancer immunology.